Delivery Order SPE2DX22D0029-SPE2D826F12PN
- Not listed
- On January 8, 2026, the Defense Logistics Agency's Medical Supply Chain division awarded a delivery order valued at $914,381.09 to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), headquartered in Conshohocken, Pennsylvania. This firm fixed-price delivery order, which is not set-aside and was competitively awarded, is scheduled for ultimate completion by January 9, 2026. AmerSourceBergen Drug Corp operates as a subsidiary of parent company Cencora, Inc. (doing business as AmerSourceBergen), a...
- On January 7, 2026, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $1,295.84 to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), a subsidiary of parent company Cencora, Inc. This firm fixed-price, non-set-aside delivery order is scheduled for completion by January 8, 2026, with performance taking place at the awardee's corporate office in Conshohocken, Pennsylvania. The delivery order represents a task order issued under a larger indefinite delivery...
- On January 8, 2026, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $34,643.25 to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), a subsidiary of parent company Cencora, Inc. This firm fixed-price delivery order, which has an ultimate completion date of January 9, 2026, was competitively awarded with no set-aside designation. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- On January 8, 2026, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $6,138.00 to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), with an ultimate completion date of January 9, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being performed in Conshohocken, Pennsylvania. The award represents a task order against AmerSourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical,...
- On January 7, 2026, the Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $14,865.12 to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), a subsidiary of parent company Cencora, Inc. (doing business as AmerSourceBergen). This firm fixed-price delivery order is scheduled for ultimate completion by January 8, 2026, with performance taking place at the awardee's corporate office in Conshohocken, Pennsylvania. The contract was awarded on a competitive basis with no...
- On January 6, 2026, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $9,374.40 to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), a subsidiary of parent company Cencora, Inc. (Doing Business As AmerSourceBergen). This firm fixed-price delivery order is not set-aside and is scheduled for ultimate completion on January 7, 2026, with performance taking place at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The award represents a task...
- On January 7, 2026, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $1,855.62 to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), a subsidiary of Cencora, Inc. This firm fixed-price delivery order, with an ultimate completion date of January 8, 2026, was competitively awarded with no set-aside designation. The contract will be performed in Conshohocken, Pennsylvania, where AmerSourceBergen Drug Corp maintains its corporate office. This delivery order...
- On January 8, 2026, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $22,525.30 to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), with a completion date of January 9, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is to be performed in Conshohocken, Pennsylvania. AmerSourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, operates as a subsidiary of parent...
- On January 6, 2026, the Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $12,276.00 to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), with an ultimate completion date of January 7, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a task order under AmerSourceBergen's parent company Cencora, Inc.'s larger indefinite delivery contract with DLA Troop Support Medical. The work will be performed at the...
- On January 8, 2026, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $6,606.72 to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This firm fixed-price, non-set-aside delivery order is scheduled for completion by January 9, 2026, with performance occurring at the awardee's Conshohocken location. The award represents a task order under AmerSourceBergen's parent company Cencora,...
- SPE2DX22D0029Indefinite Delivery Contract
- SPE2DX22D0029-SPE2D826F12PNDelivery Order
On January 7, 2026, the Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $1,038.96 to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This competitively awarded, firm fixed-price delivery order is not set aside for any specific business category and has an ultimate completion date of January 8, 2026. The award represents a child task order under AmerSourceBergen's parent company Cencora, Inc. (doing business as AmerSourceBergen), which holds a substantial $999.99 billion indefinite delivery contract with DLA Troop Support Medical through December 2031. AmerSourceBergen serves as a critical vendor for federal medical procurement, supplying a comprehensive portfolio of pharmaceutical products and medical supplies to support military healthcare programs globally. The company's federal contracting activities encompass brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. Through its primary IDC vehicle with DLA, AmerSourceBergen has demonstrated significant capacity to fulfill government requirements for essential pharmaceuticals and medical supplies serving military treatment facilities, veterans' healthcare programs, and other federal medical institutions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 1/6/26 |